NCT02492711 · Interventional trial
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer
Overall registry status Completed
Phase 3
Conditions HER-2 Positive Breast Cancer, Metastatic Neoplasm
Delaware Valley sites
- CTCA - Eastern Regional Medical Center, Inc. · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory